novo nordisk glp 1 Finds Medicare Patients Prefer GLP-1 Pill Over Shot for Weight Loss Health Rounds: Novo Nordisk's semaglutide

Turcot V, Lu Y, Highland HM, Schurmann C, Justice AE, Fine RS, et al

Most providers prefer injectable semaglutide for patients switching from injectable tirzepatide to maintain consistency in delivery method and bioavailability

Medications like Wegovy and Zepbound are tailored for weight management and are designed to reach higher doses to suppress appetite and aid in weight loss

Liraglutide for perioperative management of hyperglycaemia in cardiac surgery patients: a multicentre randomized superiority trial

Imagine, too, that not only does this miraculous sugar alternative refrain from causing harm, but it could actually make you healthier every time you eat it